Upadacitinib Receives Breakthrough Designation, Abatacept Use Expands in Australia & More Michele B. Kaufman, PharmD, BCGP | January 31, 2018The FDA has designated upadacitinib a breakthrough therapy to treat adults with moderate to severe atopic dermatitis…
